ArticleCirculation. Cardiovascular quality and outcomes2011
Physician and patient influences on provider performance: β-blockers in postmyocardial infarction management in the MI-Plus study.
Article in Circulation. Cardiovascular quality and outcomes, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00126750 (MI-Plus), which is not on this map. Cited by 8 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
MI-Plus: Web-enhanced Guideline Implementation for Post MI CBOC Patients
Who cites it
8 citing papers in PubMed, 2 syntheses or guidelines pooled it, 11 citations in OpenAlex.
- Systematic Review: Association Between Physicians' Clinical Experience and Quality of Care and Patient Outcomes.Journal of general internal medicine · 2026Pooled it
- Cardiovascular medication utilization and adherence among adults living in rural and urban areas: a systematic review and meta-analysis.BMC public health · 2014Pooled it
- Improving care after myocardial infarction using a 2-year internet-delivered intervention: the Department of Veterans Affairs myocardial infarction-plus cluster-randomized trial.Archives of internal medicine · 2011Trial
- Recruitment activities for a nationwide, population-based, group-randomized trial: the VA MI-Plus study.Implementation science : IS · 2011Trial
- Physicians' clinical experience and its association with healthcare quality: a systematised review.BMJ open quality · 2021Article
- Rural-Urban Differences in Chronic Disease and Drug Utilization in Older Oregonians.The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association · 2016Article
- Physician experience and outcomes among patients admitted to general internal medicine teaching wards.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2015Article
- Federally qualified health centers and private practice performance on ambulatory care measures.American journal of preventive medicine · 2012Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 1 country.
Funding
Abstract
backgroundEfforts to improve the quality of care for patients with cardiovascular disease frequently target the decrease of physician-level performance variability. We assessed how variability in providing β-blockers to ambulatory postmyocardial infarction (MI) patients was influenced by physician and patient level characteristics. METHODS AND
resultsβ-Blocker prescription and patient characteristics were abstracted from charts of post-MI patients treated by 133 primary care physicians between 2003 and 2007 and linked to physician and practice characteristics. Associations of β-blocker prescription with physician- and patient-level characteristics were examined using mixed-effects models, with physician-level effects as random. Mean physician-specific predicted probabilities and the intraclass correlations, which assessed the proportion of variance explainable at the physician level, were estimated. Of 1901 patients without major contraindication, 69.1% (range across physicians, 20% to 100%) were prescribed β-blockers. Prescription varied with comorbidity from 78.3% in patients with chronic kidney disease to 54.7% for patients with stroke. Although physician characteristics such as older physician age, group practice, and rural location were each positively associated with β-blocker prescription, physician factors accounted for only 5% to 8% of the variance in β-blocker prescription; the preponderance of the variance, 92% to 95%, was at the patient level. The mean physician-specific probability of β-blocker prescription (95% confidence interval) in the fully adjusted model was 63% (61% to 65%).
conclusionsβ-Blocker prescription rates were surprisingly low. The contribution of physician factors to overall variability in β-blocker prescription, however, was limited. Increasing evidence-based use of β-blockers may not be accomplished by focusing mostly on differential performance across physicians.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.